Maven Securities LTD Ascendis Pharma A/S Transaction History
Maven Securities LTD
- $539 Million
- Q4 2024
A detailed history of Maven Securities LTD transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Maven Securities LTD holds 10,000 shares of ASND stock, worth $1.52 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
10,000
Previous 50,000
80.0%
Holding current value
$1.52 Million
Previous $7.47 Million
81.57%
% of portfolio
0.26%
Previous 0.96%
Shares
5 transactions
Others Institutions Holding ASND
# of Institutions
236Shares Held
60.2MCall Options Held
80.3KPut Options Held
216K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.54 Billion22.55% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.53MShares$842 Million3.52% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.1MShares$777 Million10.24% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.45MShares$678 Million0.98% of portfolio
-
Janus Henderson Group PLC London, X04.38MShares$667 Million0.32% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.5B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...